APD vs PLX · P/E 30, rev $12.04B vs P/E 31, rev $53.4M
Air Products and Chemicals Inc (APD) versus Protalix Biotherapeutics Inc (PLX) — a side-by-side from cached financials, not a winner call.
Air Products and Chemicals Inc (APD) is a specialty chemicals company listed on NYSE.
Protalix Biotherapeutics Inc (PLX) is a biotechnology company listed on US.
Latest reported APD revenue for 2025-09-30 was $12.04B. Net income was -$354.4M. Revenue was down 0.5% from 2024-09-30 to 2025-09-30. APD currently screens at market cap $62.74B and trailing P/E 29.7.
Latest reported PLX revenue for 2024-12-31 was $53.4M. Net income was $2.9M. Revenue was down 18.5% from 2023-12-31 to 2024-12-31. PLX currently screens at market cap $122.6M and trailing P/E 30.8.
APD currently screens at market cap $62.74B and trailing P/E 29.7. PLX currently screens at market cap $122.6M and trailing P/E 30.8.
Not investment advice. Open the APD and PLX stock pages for the full models.
Not investment advice.